Shah et al., 2020 - Google Patents
Salvage craniotomy for treatment-refractory symptomatic cerebral radiation necrosisShah et al., 2020
View HTML- Document ID
- 15604343851723306194
- Author
- Shah A
- Mahavadi A
- Morell A
- Eichberg D
- Luther E
- Sarkiss C
- Semonche A
- Ivan M
- Komotar R
- Publication year
- Publication venue
- Neuro-oncology practice
External Links
Snippet
Background The incidence of symptomatic radiation necrosis (RN) has risen as radiotherapy is increasingly used to control brain tumor progression. Traditionally managed with steroids, symptomatic RN can remain refractory to medical treatment, requiring surgical intervention …
- 206010067362 Radiation necrosis 0 title abstract description 71
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
- A61N5/1077—Beam delivery systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
- A61N2005/1092—Details
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
- A61N5/103—Treatment planning systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, progesterone
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06Q—DATA PROCESSING SYSTEMS OR METHODS, SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES, NOT OTHERWISE PROVIDED FOR
- G06Q50/00—Systems or methods specially adapted for a specific business sector, e.g. utilities or tourism
- G06Q50/10—Services
- G06Q50/22—Health care, e.g. hospitals; Social work
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Iwata et al. | Hypofractionated stereotactic radiotherapy with CyberKnife for nonfunctioning pituitary adenoma: high local control with low toxicity | |
Tsai et al. | Hippocampal dosimetry correlates with the change in neurocognitive function after hippocampal sparing during whole brain radiotherapy: a prospective study | |
Minniti et al. | Fractionated stereotactic conformal radiotherapy for secreting and nonsecreting pituitary adenomas | |
Goda et al. | Hippocampal radiotherapy dose constraints for predicting long-term neurocognitive outcomes: mature data from a prospective trial in young patients with brain tumors | |
Vicini et al. | First analysis of patient demographics, technical reproducibility, cosmesis, and early toxicity: results of the American Society of Breast Surgeons MammoSite Breast Brachytherapy Registry Trial | |
Petit et al. | Proton stereotactic radiotherapy for persistent adrenocorticotropin-producing adenomas | |
Halasz et al. | Proton stereotactic radiosurgery for the treatment of benign meningiomas | |
Meng et al. | Clinical features and prognostic factors of patients with chordoma in the spine: a retrospective analysis of 153 patients in a single center | |
Dincoglan et al. | Management of patients with recurrent glioblastoma using hypofractionated stereotactic radiotherapy | |
Yazici et al. | Hypofractionated stereotactic reirradiation for recurrent glioblastoma | |
Hanakita et al. | The long-term outcomes of radiosurgery for intracranial hemangioblastomas | |
Shah et al. | Salvage craniotomy for treatment-refractory symptomatic cerebral radiation necrosis | |
Hua et al. | Prognostic value of estrogen receptor in WHO Grade III meningioma: a long-term follow-up study from a single institution | |
Moraes et al. | Outcomes following stereotactic radiosurgery for small to medium-sized brain metastases are exceptionally dependent upon tumor size and prescribed dose | |
Combs et al. | Treatment of patients with atypical meningiomas Simpson grade 4 and 5 with a carbon ion boost in combination with postoperative photon radiotherapy: the MARCIE trial | |
Bunevicius et al. | Surgical and radiosurgical treatment strategies for Cushing’s disease | |
Labuschagne et al. | Glioblastoma multiforme as a secondary malignancy following stereotactic radiosurgery of a meningioma: case report | |
Sato et al. | Long-term outcomes of patients with unresectable benign meningioma treated with proton beam therapy | |
Merchant et al. | Endocrine outcomes after limited surgery and conformal photon radiation therapy for pediatric craniopharyngioma: Long-term results from the RT1 protocol | |
Vik-Mo et al. | Gamma knife stereotactic radiosurgery of Nelson syndrome | |
De Sanctis et al. | Communicating hydrocephalus after radiosurgery for vestibular schwannomas: does technique matter? A systematic review and meta-analysis | |
Beddok et al. | Proton therapy for adult craniopharyngioma: experience of a single institution in 91 consecutive patients | |
Howard et al. | The evolving role for re-irradiation in the management of recurrent grade 4 glioma | |
Shinohara et al. | Longitudinal comparison of quality of life after real-time tumor-tracking intensity-modulated radiation therapy and radical prostatectomy in patients with localized prostate cancer | |
Ioakeim-Ioannidou et al. | Surgery and proton radiation therapy for pediatric base of skull chordomas: Long-term clinical outcomes for 204 patients |